Engraftment of human chronic lymphocytic leukemia cells in SCID mice: In vivo and in vitro studies

Leukemia

Volumn 10, Issue 8, 1996, Pages 1370-1376

  Hummel, J L ^a   Lichty, B D ^b   Reis, M ^b,c   Dube I ^a,b,c   Kamel Reid, S ^a,b,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Chronic lymphocytic leukemia; Cytokines; Epstein Barr virus; SCID mice; Thymic tumours; Transplantation

Indexed keywords

CD5 ANTIGEN; DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER CARCINOMA; BONE MARROW; CANCER MODEL; CELL TRANSPLANTATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FLUORESCENCE ACTIVATED CELL SORTER; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; KIDNEY; LEUKEMIA CELL; LUNG; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCID MOUSE; SOUTHERN BLOTTING; SPLEEN; THYMUS LYMPHOMA;

EID: 0029744948     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Canellos GP. Chronic Leukemias: Hematol/Oncol Clin North Am 1990; 4: 405-471.
2. Rai KR, Han T. Prognostic factors and clinical staging in chronic lymphocytic leukemia. Hematol/Oncol Clin North Am 1990; 4: 447-456.
3. Dighiero G, Travade P, Chevret S, Fenaux P, Chastang C, Binet JL and The French Cooperative Group on CLL. B-cell chronic lymphocytic leukemia: present status and future directions. Blood 1991; 78: 1901-1914.
4. Montserrat E, Binet L, Catovsky D, Dighiero G, Gale RP, Rai KR, Rozman C. 5th International Workshop on Chronic Lymphocytic Leukemia. Leukemia Res 1992; 16: 717-720.
5. Perl A, DiVincenzo JP, Ryan DH, Gergely P, Szigeti A, Feher J, Abraham GN. Rearrangement of the T-cell receptor alpha, beta and gamma chain genes in chronic lymphocytic leukemia. Leukemia Res 1990; 14: 131-137.
6. Lenormand B, Ghanem N, Tilly H, Boussemart C, Monconduit M, Piguet H, Lefranc G, Lefranc MP. Rearrangements of immunoglobulin light and heavy chain genes and correlation with phenotypic markers in B-cell chronic lymphocytic leukemia. Leukemia 1991; 5: 928-936.
7. Liang R, Chan V, Chan TK, Chiu E, Todd D. Rearrangement of immunoglobulin and T cell receptor genes in acute and chronic leukaemias. Acta Haematol 1991; 85: 71-75.
8. Freedman AS. Immunobiology of chronic lymphocytic leukemia. Hematol/Oncol Clin North Am 1990; 4: 405-429.
9. Block AW. Cytogenetic analysis of B-cell chronic lymphoproliferative disorders: new technology, complexities and promises. Fragile X/Cancer Cytogenetics. Wiley-Liss: New York, 1991, pp 145-173.
10. Foon KA, Rai KR, Gale RP. Chronic lymphocytic leukemia: new insights into biology and therapy. Ann Intern Med 1990; 113: 525-539.
11. Karande A, Fialkow PJ, Nilsson K, Povey S, Klein G, Najfeld V, Penfold G. Establishment of a lymphoid cell line from leukemic cells of a patient with chronic lymphocytic leukemia. Int J Cancer 1980; 26: 551-556.
12. Rickinson A, Finerty S, Epstein MA. Interaction of Epstein-Barr virus with leukaemic B cells in vitro. I. Abortive infection and rare cell line establishment from chronic lymphocytic leukaemic cells. Clin Exp Immunol 1982; 50: 347-354.
13. Kamel-Reid S, Letarte M, Sirard C, Doedens M, Grunberger T, Fulop G, Freedman MH, Phillips RA, Dick JE. A model of human acute lymphoblastic leukemia in immune-deficient scid mice. Science 1989; 246: 1597-1600.
14. Kamel-Reid S, Letarte M, Doedens M, Greaves A, Murdoch B, Grunberger T, Lapidot T, Thorner P, Freedman MH, Phillips RA, Dick JE. Bone marrow from children in relapse with pre-B acute lymphoblastic leukemia proliferates and disseminates rapidly in scid mice. Blood 1991; 78: 2973-2981.
15. Kamel-Reid S, Dick JE, Greaves A, Murdoch B, Doedens, M, Grunberger T, Thorner P, Freedman MH, Phillips RA, Letarte M. Differential kinetics of engraftment and induction of CD10 on human pre-B leukemia cell lines in immune deficient scid mice. Leukemia 1992; 6: 8-17.
16. Uckun FM, Downing JR, Gunther R, Chelstrom LM, Finnegan D, Land VJ, Borowitz MJ, Carroll AJ, Crist WM. Human t(1;19)(q23;p13) pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiency. Blood 1993; 81: 3052-3062.
17. Waye JS, Willard HF. Nucleotide sequence heterogeneity of alpha satellite repetitive DNA: a survey of alphoid sequences from different human chromosomes. Nucleic Acids Res 1987; 15: 7549-7569.
18. Kamel-Reid S, Dick JE. Engraftment of immune-deficient mice with human hematopoietic stem cells. Science 1988; 242: 1706-1709.
19. Bienzle D, Abrams-Ogg ACG, Kruth SA, Ackland-Snow J, Carter RF, Dick JE, Jacobs RM, Kamel-Reid S, Dubé ID. Gene transfer into hematopoietic stem cells: long-term maintenance of in vitro activated progenitors without marrow ablation. Proc Natl Acad Sci USA 1994; 91: 350-354.
20. Digel W, Schmid M, Heil G, Conrad P, Gillis S, Porzsolt F. Human interleukin-7 induces proliferation of neoplastic cells from chronic lymphocytic leukemia and acute leukemia. Blood 1991; 78: 753-759.
21. Nilsson K, Larsson LG, Carlsson M. Control of growth and differentiation of B-type chronic lymphocytic leukemia cells in vitro. Leukemia 1992; 6 (Suppl. 3): 20S-21S.
22. Glück U, Zipori D, Wetzler M, Berrebi A, Shaklai M, Drezen O, Zaizov R, Luria D, Marcelle C, Stark B, Umiel T. Long-term proliferation of human leukemia cells induced by mouse stroma. Exp Hematol 1989; 17: 398-404.
23. Sawitsky B, Douglas SD, Lipton R, Sawitsky A. Biochemical and morphological observations on lymphocytes in continuous cell culture from a patient with chronic lymphocytic leukemia. Acta Hematol 1974; 52: 83-94.
24. 2 from contingency tables and the calculation of P. J Roy Stat Soc 1992; 85: 87-94.
25. Lapidot T, Pflumio F, Doedens M, Murdoch B, Williams DE, Dick JE. Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in scid mice. Science 1992; 255: 1137-1141.
26. Touw I, Dorssers L, Lowenberg B. The proliferative response of B cell chronic lymphocytic leukemia to interleukin 2: functional characterization of the interleukin 2 membrane receptors. Blood 1987; 69: 1667-1673.
27. Nerl C, Janssen O, Kabelitz D. B cell maturation in chronic lymphocytic leukemia. III. Effect of recombinant cytokines on leukemic B cell proliferation. Leukemia 1988; 2: 50S-56S.
28. Brizard A, Morel F, Lectron JC, Dreyfus B, Brizard F, Barra A, Preud'Homme JL. Proliferative response of B chronic lymphocytic leukemia lymphocytes stimulated with IL2 and soluble CD23. Leuk Lymphoma 1994; 14: 311-318.
29. Boumsell L, Bernard A, Lepage V. Some chronic lymphocytic leukemia cells bearing surface immunoglobulins share determinants with T cells. Eur J Immunol 1978; 8: 900-904.
30. Royston I, Majda JA, Baird SM et al. Human T-cell antigens defined by monoclonal antibodies: the 65,000 dalton antigen of T-cells (T65) is also found on chronic lymphocytic leukemia cells bearing surface immunoglobulin. J Immunol 1980; 125: 725-731.
31. Ishihara S, Tachibana N, Okayama A, Murai K, Tsuda K, Mueller N. Successful graft of HTLV-I-transformed human T-cells (MT-2) in severe combined immunodeficiency mice treated with anti-asialo GM-I antibody. Jpn J Cancer Res 1992; 83: 320-323.
32. Mosier DE, Gulizia RJ, Baird SM, Wilson DB. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 1988; 335: 256-259.
33. McCune JM, Namikawa R, Kaneshima H, Shultz LD, Lieberman M, Weissman IL. The scid-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 1988; 241: 1632-1639.
34. Waller EK, Kamel OW, Cleary ML, Majumdar AS, Schick MR, Lieberman M, Weissman IL. Growth of primary T-cell non-Hodgkin's lymphoma in SCID-hu mice: requirement for a human lymphoid microenvironment. Blood 1991; 78: 2650-2665.
35. Kyoizumi S, Baum CM, Kaneshima H, McCune JM, Yee EJ, Namikawa R. Implantation and maintenance of functional human bone marrow in SCID-hu mice. Blood 1992; 79: 1704-1711.
36. Namikawa R, Ueda R, Kyoizumi S. Growth of human myeloid leukemias in the human marrow environment of SCID-hu mice. Blood 1993; 82: 2526-2536.
37. Carlsson M, Totterman TH, Rosen A, Nilsson K. Interleukin-2 and a T-cell hybridoma (MP6) derived B-cell-stimulatory factor act synergistically to induce proliferation and differentiation of human B-chronic lymphocytic leukemia cells. Leukemia 1989; 3: 593-601.
38. Foa R, Tos AG, di celle PF, Carbone A, Marchis D, Vischia F, Cignetti A, Guarini A. Cytokines in B-cell chronic lymphocytic leukemia. Leuk Lymphoma 1991; (Suppl): 7-11.
39. Hoffbrand AV, Panayiotidis P, Reittie J, Ganesharguru K. Autocrine and paracrine growth loops in chronic lymphocytic leukemia: Semin Hematol 1993; 30: 306-317.
40. Kooten CV, Rensink I, Aarden L, Van Oers R. Interleukin-4 inhibits both paracrine and autocrine tumor necrosis factor-α-induced proliferation of B chronic lymphocytic leukemia cells. Blood 1992; 80: 1299-1306.
41. Kooten CV, Rensink I, Aarden L, Van Oers R. Cytokines and intracellular signals involved in the regulation of B-cell proliferation. Leuk Lymphoma 1993; 12: 27-33.
42. Fulop GM, Phillips RA. The scid mutation in mice causes a general defect in DNA repair. Nature 1990; 347: 479-482.
43. Lieberman M, Hansteen GA, Waller EK, Weissman IL, SenMajumdar A. Unexpected effects of the severe combined immunodeficiency mutation on murine lymphomagenesis. J Exp Med 1992; 176: 399-405.
44. Custer RP, Bosma GC, Bosma MJ. Severe combined immunodeficiency (SCID) in the mouse: pathology, reconstitution, neoplasms. Am J Pathol 1985; 120: 464-477.
45. Monticello TM, Green DS, Yang H, Drain RL, Franco CT, Durham SK. Spontaneous thymic lymphoma in severe combined immunodeficiency (SCID) mice engrafted with human peripheral blood lymphocytes. Vet Pathol 1994; 31: 393-395.
46. Cannon MJ, Pisa P, Fox RI, Cooper NR. Epstein-Barr virus induces aggressive lymphoproliferative disorders of human B cell origin in SCID/hu chimeric mice. J Clin Invest 1990; 85: 1333-1337.
47. Rowe M, Young LS, Crocker J, Stokes H, Henderson S, Rickinson AB. Epstein-Barr virus (EBV)-associated lymphoproliferative disease in SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man. J Exp Med 1991; 173: 147-158.
48. Kobayashi R, Picchio G, Kirven M, Meisenholder G, Baird S, Carson DA, Mosier DE, Kipps TJ. Transfer of human chronic lymphocytic leukemia to mice with severe combined immune deficiency. Leukemia Res 1992; 16: 1013-1023.
49. Itoh T, Shiota M, Takanashi M, Hojo I, Satoh H, Matsuzawa A, Moriyama T, Watanabe T, Hirai K, Mori S. Engraftment of human non-Hodgkin lymphomas in mice with severe combined immunodeficiency. Cancer 1993; 72: 2686-2694.
50. Baiocchi RA, Caligiuri MA. Low-dose interleukin 2 prevents the development of Epstein-Barr virus (EBV)-associated lymphoproliferative disease in scid/scid mice reconstituted I.P. with EBV-seropositive human peripheral blood lymphocytes. Proc Natl Acad Sci USA 1994; 91: 5577-5581.